Top Markets
Coin of the day
Argenica Therapeutics Ltd Argenica Therapeutics Ltd

Argenica Therapeutics Ltd

AGN
Rang in aandelen #30346
Argenica Therapeutics Limited, a biotechnology company, engages in the research... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Aandeelprijs
$0.14599395
Marktkapitalisatie
$18.75M
Verandering (1 dag)
0.98%
Verandering (1 jaar)
-67.69%
Land
AU
Handel Argenica Therapeutics Ltd (AGN)

Categorie

Dividendrendementgeschiedenis voor Argenica Therapeutics Ltd (AGN)
Het dividendrendement (TTM) van Argenica Therapeutics Ltd (aandelsymbool: AGN) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Argenica Therapeutics Ltd (AGN) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten